Osteogenesis Imperfecta, Type I clinical trials at UCSF
1 in progress, 0 open to new patients
Sorry, not currently recruiting here
The purpose of this study is to select a suitable dose of BPS804 by comparing it with a dummy treatment and measuring the strength/quality of bone using a special type of CT scanner. Participants will be treated for 1 year.
San Francisco, California and other locations